ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line

PURPOSE: This study aimed to validate the synergistic effect of ABT-737 on docetaxel using MDA-MB-231, a triple negative breast cancer (TNBC) cell line overexpressing B-cell lymphoma-2 (Bcl-2). METHODS: Western blot analysis was performed to assess expression levels of Bcl-2 family proteins and casp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Eunjoo, Hwang, Seong-Hye, Kim, Jongjin, Park, Jin Hyun, Oh, Sohee, Kim, Young A, Hwang, Ki-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204323/
https://www.ncbi.nlm.nih.gov/pubmed/30402442
http://dx.doi.org/10.4174/astr.2018.95.5.240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204323/
https://www.ncbi.nlm.nih.gov/pubmed/30402442
http://dx.doi.org/10.4174/astr.2018.95.5.240

Ejemplares similares